There is a close association between sarcopenia and diabetic peripheral neuropathy.
Adding nerve ultrasound to nerve conduction studies improves detection of chronic inflammatory neuropathies in patients with suspected chronic inflammatory neuropathy.
Larger contralateral trigeminal nerve and hippocampus volumes are predictive of early nonresponse to surgical treatment of trigeminal neuralgia.
The FDA has a supplemental New Drug Application for capsaicin 8% patch for the treatment of neuropathic pain associated with diabetic peripheral neuropathy.
Higher systolic blood pressure and decreased low-density lipoprotein are associated with increased risk for peripheral neuropathy in patients with type 2 diabetes.
Although the prevalence of distal sensory peripheral neuropathy decreased following initiation of cART in people living with in resource-limiting settings, better strategies are needed.
Amphiphysin-IgG-mediated autoimmunity is an important clinical entity characterized by neuropathy.
When traditional oral analgesics no longer control pain, some physicians are turning to alternative drug delivery methods that provide pain relief while avoiding systemic adverse effects.
This study provides normative values for the bilateral lumbar and sacral-anorectal MEPs in healthy subject with no age or gender influence on rectal or anal MEP latency.
BoNT-A showed significant improvements in the frequency and severity of photophobia and eye discomfort.